Knockout and Replacement Gene Surgery to Treat Rhodopsin-Mediated Autosomal Dominant Retinitis Pigmentosa
Human Gene Therapy · 2024
DOI: 10.1089/hum.2023.201 ↗Kurz gefasst
Fachartikel in der Zeitschrift Human Gene Therapy, 2024. Verfasst von Xuehan Sun und 8 weiteren Autor:innen. Beteiligte Einrichtung: State Key Laboratory of Stem Cell and Reproductive Biology, Institute of Zoology, Chinese Academy of Sciences, Beijing, China. Hauptthemen laut MEDLINE: Retinitis Pigmentosa, Retinal Degeneration. Die Arbeit wurde bisher 10-mal zitiert (Crossref) und nennt 40 Literaturangaben.
Abstract (Originalsprache)
Mutations in the rhodopsin (RHO) gene are the predominant causes of autosomal dominant retinitis pigmentosa (adRP). Given the diverse gain-of-function mutations, therapeutic strategies targeting specific sequences face significant challenges. Here, we provide a universal approach to conquer this problem: we have devised a CRISPR-Cas12i-based, mutation-independent gene knockout and replacement compound therapy carried by a dual AAV2/8 system. In this study, we successfully delayed the progression of retinal degeneration in the classic mouse disease model RhoP23H, and also RhoP347S, a new native mouse mutation model we developed. Our research expands the horizon of potential options for future treatments of RHO-mediated adRP.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- State Key Laboratory of Stem Cell and Reproductive Biology, Institute of Zoology, Chinese Academy of Sciences, Beijing, China.
- Key Laboratory of Organ Regeneration and Reconstruction, Chinese Academy of Sciences, Beijing, China.
- University of Chinese Academy of Sciences, Beijing, China; and.
- Beijing Institute for Stem Cell and Regenerative Medicine, Beijing, China.
ORCID-Profile: Xuehan Sun
Zitieren
APA
Sun, X., Liang, C., Chen, Y., Cui, T., Han, J., Dai, M., Zhang, Y., Zhou, Q., & Li, W. (2024). Knockout and Replacement Gene Surgery to Treat Rhodopsin-Mediated Autosomal Dominant Retinitis Pigmentosa. Human Gene Therapy. https://doi.org/10.1089/hum.2023.201
Vancouver
Sun X, Liang C, Chen Y, Cui T, Han J, Dai M, et al. Knockout and Replacement Gene Surgery to Treat Rhodopsin-Mediated Autosomal Dominant Retinitis Pigmentosa. Human Gene Therapy. 2024. doi:10.1089/hum.2023.201
BibTeX
@article{Sun2024,
author = {Sun, Xuehan and Liang, Chen and Chen, Yangcan and Cui, Tongtong and Han, Jiabao and Dai, Moyu and Zhang, Ying and Zhou, Qi and Li, Wei},
title = {Knockout and Replacement Gene Surgery to Treat Rhodopsin-Mediated Autosomal Dominant Retinitis Pigmentosa},
journal = {Human Gene Therapy},
year = {2024},
doi = {10.1089/hum.2023.201}
}
EUVIMED